{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:27:30Z","timestamp":1780626450006,"version":"3.54.1"},"reference-count":80,"publisher":"International Society of Endovascular Specialists","issue":"SupplementII","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1583\/08-2654.1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T12:45:36Z","timestamp":1243860336000},"page":"II82-II97","source":"Crossref","is-referenced-by-count":29,"title":["Evolving Modalities for Femoropopliteal Interventions"],"prefix":"10.1583","volume":"16","author":[{"given":"Gary M.","family":"Ansel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Lumsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"527","reference":[{"key":"i1545-1550-16-SupplementII-82-b1","doi-asserted-by":"crossref","unstructured":"K. J. Rocha-Singh, M. R. Jaff, and T. R. Crabtree .et al.Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease., Catheter Cardiovasc Interv, 2007 .69 :910 \u2013919 .","DOI":"10.1002\/ccd.21104"},{"key":"i1545-1550-16-SupplementII-82-b2","unstructured":"J. A. Dormandy, and R. B. Rutherford .Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)., J Vasc Surg, 2000 .31 :(1 Pt 2).S1 \u2013S296 ."},{"key":"i1545-1550-16-SupplementII-82-b3","doi-asserted-by":"crossref","unstructured":"L. Norgren, W. R. Hiatt, and J. A. Dormandy .et al.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)., J Vasc Surg, 2007 .45 :(1 Suppl).S5 \u2013S67 .","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"i1545-1550-16-SupplementII-82-b4","doi-asserted-by":"crossref","unstructured":"J. R. Laird, Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries., J Endovasc Ther, 2006 .13 :(Suppl II).II30 \u201340 .","DOI":"10.1177\/15266028060130S207"},{"key":"i1545-1550-16-SupplementII-82-b5","doi-asserted-by":"crossref","unstructured":"T. Reifsnyder, J. P. Grossman, and S. A. Leers .Limb loss after lower extremity bypass., Am J Surg, 1997 .174 :149 \u2013151 .","DOI":"10.1016\/S0002-9610(97)90074-X"},{"key":"i1545-1550-16-SupplementII-82-b6","unstructured":"V. Dorrucci, Treatment of superficial femoral artery occlusive disease., J Cardiovasc Surg (Torino), 2004 .45 :193 \u2013201 ."},{"key":"i1545-1550-16-SupplementII-82-b7","doi-asserted-by":"crossref","unstructured":"B. H. Gray, T. M. Sullivan, and M. B. Childs .et al.High incidence of restenosis\/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty., J Vasc Surg, 1997 .25 :74 \u201383 .","DOI":"10.1016\/S0741-5214(97)70323-9"},{"key":"i1545-1550-16-SupplementII-82-b8","doi-asserted-by":"crossref","unstructured":"J. P. Becquemin, J. P. Favre, and J. Marzelle .et al.Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study., J Vasc Surg, 2003 .37 :487 \u2013494 .","DOI":"10.1067\/mva.2003.155"},{"key":"i1545-1550-16-SupplementII-82-b9","doi-asserted-by":"crossref","unstructured":"M. Cejna, S. Thurnher, and H. Illiasch .et al.PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study., J Vasc Interv Radiol, 2001 .12 :23 \u201331 .","DOI":"10.1016\/S1051-0443(07)61397-9"},{"key":"i1545-1550-16-SupplementII-82-b10","doi-asserted-by":"crossref","unstructured":"D. Vroegindeweij, L. D. Vos, and A. V. Tielbeek .et al.Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study., Cardiovasc Intervent Radiol, 1997 .20 :420 \u2013425 .","DOI":"10.1007\/s002709900186"},{"key":"i1545-1550-16-SupplementII-82-b11","doi-asserted-by":"crossref","unstructured":"H. F. Lugmayr, H. Holzer, and M. Kastner .et al.Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up., Radiology, 2002 .222 :37 \u201343 .","DOI":"10.1148\/radiol.2221010268"},{"key":"i1545-1550-16-SupplementII-82-b12","doi-asserted-by":"crossref","unstructured":"M. Henry, I. Henry, and C. Klonaris .et al.Clinical experience with the OptiMed sinus stent in the peripheral arteries., J Endovasc Ther, 2003 .10 :772 \u2013779 .","DOI":"10.1177\/152660280301000414"},{"key":"i1545-1550-16-SupplementII-82-b13","doi-asserted-by":"crossref","unstructured":"S. H. Duda, B. Pusich, and G. Richter .et al.Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results., Circulation, 2002 .106 :1505 \u20131509 .","DOI":"10.1161\/01.CIR.0000029746.10018.36"},{"key":"i1545-1550-16-SupplementII-82-b14","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial., J Vasc Interv Radiol, 2005 .16 :331 \u2013338 .","DOI":"10.1097\/01.RVI.0000151260.74519.CA"},{"key":"i1545-1550-16-SupplementII-82-b15","doi-asserted-by":"crossref","unstructured":"D. Scheinert, S. Scheinert, and J. Sax .et al.Prevalence and clinical impact of stent fractures after femoropopliteal stenting., J Am Coll Cardiol, 2005 .45 :312 \u2013315 .","DOI":"10.1016\/j.jacc.2004.11.026"},{"key":"i1545-1550-16-SupplementII-82-b16","doi-asserted-by":"crossref","unstructured":"S. Sabeti, W. Mlekusch, and J. Amighi .et al.Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries., J Endovasc Ther, 2005 .12 :6 \u201312 .","DOI":"10.1583\/04-1359.1"},{"key":"i1545-1550-16-SupplementII-82-b17","doi-asserted-by":"crossref","unstructured":"O. Schlager, P. Dick, and S. Sabeti .et al.Long-segment SFA stenting\u2013the dark sides: in-stent restenosis, clinical deterioration, and stent fractures., J Endovasc Ther, 2005 .12 :676 \u2013684 .","DOI":"10.1583\/05-1672.1"},{"key":"i1545-1550-16-SupplementII-82-b18","unstructured":"D. Allie, C. Hebert, and C. Walker .Nitinol stent fractures in the SFA., Endovascular Today, July\/August 2004 .22 \u201334 ."},{"key":"i1545-1550-16-SupplementII-82-b19","doi-asserted-by":"crossref","unstructured":"H. Krankenberg, M. Schluter, and H. J. Steinkamp .et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)., Circulation, 2007 .116 :285 \u2013292 .","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"i1545-1550-16-SupplementII-82-b20","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and P. Dick .et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting., Circulation, 2007 .115 :2745 \u20132749 .","DOI":"10.1161\/CIRCULATIONAHA.107.688341"},{"key":"i1545-1550-16-SupplementII-82-b21","unstructured":"J. Laird, Lessons learned in RESILIENT (interview)., Endovascular Today, 2008 .October :59 \u201362 ."},{"key":"i1545-1550-16-SupplementII-82-b22","doi-asserted-by":"crossref","unstructured":"J. C. Parodi, J. C. Palmaz, and H. D. Barone .Transfemoral intraluminal graft implantation for abdominal aortic aneurysms., Ann Vasc Surg, 1991 .5 :491 \u2013499 .","DOI":"10.1007\/BF02015271"},{"key":"i1545-1550-16-SupplementII-82-b23","doi-asserted-by":"crossref","unstructured":"M. L. Marin, F. J. Veith, and T. F. Panetta .et al.Percutaneous transfemoral insertion of a stented graft to repair a traumatic femoral arteriovenous fistula., J Vasc Surg, 1993 .18 :299 \u2013302 .","DOI":"10.1016\/0741-5214(93)90611-O"},{"key":"i1545-1550-16-SupplementII-82-b24","doi-asserted-by":"crossref","unstructured":"J. Lammer, M. D. Dake, and J. Bleyn .et al.Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group., Radiology, 2000 .217 :95 \u2013104 .","DOI":"10.1148\/radiology.217.1.r00se0595"},{"key":"i1545-1550-16-SupplementII-82-b25","doi-asserted-by":"crossref","unstructured":"M. Fischer, C. Schwabe, and K. L. Schulte .Value of the Hemobahn\/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience., J Endovasc Ther, 2006 .13 :281 \u2013290 .","DOI":"10.1583\/05-1799.1"},{"key":"i1545-1550-16-SupplementII-82-b26","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, J. M. Coffman, and J. M. Gooding .et al.Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions., J Vasc Interv Radiol, 2007 .18 :1341 \u20131349 .","DOI":"10.1016\/j.jvir.2007.07.011"},{"key":"i1545-1550-16-SupplementII-82-b27","doi-asserted-by":"crossref","unstructured":"Y. S. Alimi, Z. Hakam, and O. Hartung .et al.Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg, 2008 .35 :346 \u2013352 .","DOI":"10.1016\/j.ejvs.2007.09.005"},{"key":"i1545-1550-16-SupplementII-82-b28","doi-asserted-by":"crossref","unstructured":"M. Henry, M. Amor, and A. Cragg .et al.Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system., Radiology, 1996 .201 :717 \u2013724 .","DOI":"10.1148\/radiology.201.3.8939221"},{"key":"i1545-1550-16-SupplementII-82-b29","doi-asserted-by":"crossref","unstructured":"J. Link, S. Muller-Hulsbeck, and J. Brossmann .et al.Perivascular inflammatory reaction after percutaneous placement of covered stents., Cardiovasc Intervent Radiol, 1996 .19 :345 \u2013347 .","DOI":"10.1007\/BF02570188"},{"key":"i1545-1550-16-SupplementII-82-b30","doi-asserted-by":"crossref","unstructured":"M. Maynar, R. Reyes, and H. Ferral .et al.Cragg Endopro System I: early experience. I. Femoral arteries., J Vasc Interv Radiol, 1997 .8 :203 \u2013207 .","DOI":"10.1016\/S1051-0443(97)70540-2"},{"key":"i1545-1550-16-SupplementII-82-b31","doi-asserted-by":"crossref","unstructured":"R. Ahmadi, M. Schillinger, and T. Maca .et al.Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft., Radiology, 2002 .223 :345 \u2013350 .","DOI":"10.1148\/radiol.2232010971"},{"key":"i1545-1550-16-SupplementII-82-b32","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, C. F. Botti, and M. J. Silver .The use of femoropopliteal stent-grafts for critical limb ischemia., Tech Vasc Interv Radiol, 2005 .8 :140 \u2013145 .","DOI":"10.1053\/j.tvir.2006.04.002"},{"key":"i1545-1550-16-SupplementII-82-b33","doi-asserted-by":"crossref","unstructured":"M. L. Marin, F. J. Veith, and J. Cynamon .et al.Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease., J Vasc Surg, 1995 .21 :595 \u2013603 .","DOI":"10.1016\/S0741-5214(95)70191-5"},{"key":"i1545-1550-16-SupplementII-82-b34","doi-asserted-by":"crossref","unstructured":"M. L. Marin, F. J. Veith, and J. Cynamon .et al.Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries., J Vasc Interv Radiol, 1996 .7 :651 \u2013656 .","DOI":"10.1016\/S1051-0443(96)70823-0"},{"key":"i1545-1550-16-SupplementII-82-b35","doi-asserted-by":"crossref","unstructured":"P. Zilla, M. Deutsch, and J. Meinhart .et al.Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years., J Vasc Surg, 1994 .19 :540 \u2013548 .","DOI":"10.1016\/S0741-5214(94)70083-4"},{"key":"i1545-1550-16-SupplementII-82-b36","doi-asserted-by":"crossref","unstructured":"G. Bauermeister, Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease., J Endovasc Ther, 2001 .8 :315 \u2013320 .","DOI":"10.1177\/152660280100800312"},{"key":"i1545-1550-16-SupplementII-82-b37","doi-asserted-by":"crossref","unstructured":"H. A. Deutschmann, P. Schedlbauer, and V. Berczi .et al.Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients., J Vasc Interv Radiol, 2001 .12 :943 \u2013950 .","DOI":"10.1016\/S1051-0443(07)61574-7"},{"key":"i1545-1550-16-SupplementII-82-b38","unstructured":"M. Railo, W. D. Roth, and J. Edgren .et al.Preliminary results with endoluminal femoropopliteal thrupass., Ann Chir Gynaecol, 2001 .90 :15 \u201318 ."},{"key":"i1545-1550-16-SupplementII-82-b39","doi-asserted-by":"crossref","unstructured":"P. J. Bray, W. J. Robson, and A. E. Bray .Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft., J Endovasc Ther, 2003 .10 :619 \u2013628 .","DOI":"10.1177\/152660280301000331"},{"key":"i1545-1550-16-SupplementII-82-b40","doi-asserted-by":"crossref","unstructured":"T. Jahnke, R. Andresen, and S. M\u00fcller-H\u00fclsbeck .et al.Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial., J Vasc Interv Radiol, 2003 .14 :41 \u201351 .","DOI":"10.1097\/01.RVI.0000052290.26939.cb"},{"key":"i1545-1550-16-SupplementII-82-b41","unstructured":"K. Daenens, G. Maleux, and I. Fourneau .et al.Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease., J Cardiovasc Surg (Torino), 2005 .46 :25 \u201329 ."},{"key":"i1545-1550-16-SupplementII-82-b42","doi-asserted-by":"crossref","unstructured":"J. Kedora, S. Hohmann, and W. Garrett .et al.Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease., J Vasc Surg, 2007 .45 :10 \u201316 .","DOI":"10.1016\/j.jvs.2006.08.074"},{"key":"i1545-1550-16-SupplementII-82-b43","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, J. M. Coffman, and J. M. Gooding .et al.Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial., J Vasc Interv Radiol, 2003 .14 :303 \u2013311 .","DOI":"10.1097\/01.RVI.0000058425.01661.d0"},{"key":"i1545-1550-16-SupplementII-82-b44","doi-asserted-by":"crossref","unstructured":"O. Hartung, A. Otero, and M. Dubuc .et al.Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants., Eur J Vasc Endovasc Surg, 2005 .30 :300 \u2013306 .","DOI":"10.1016\/j.ejvs.2005.04.027"},{"key":"i1545-1550-16-SupplementII-82-b45","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, J. M. Coffman, and J. M. Gooding .et al.Endograft use in the femoral and popliteal arteries., Tech Vasc Interv Radiol, 2004 .7 :6 \u201315 .","DOI":"10.1053\/j.tvir.2004.01.005"},{"key":"i1545-1550-16-SupplementII-82-b46","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, M. D. Dake, and R. L. Volgelzang .et al.Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease., J Vasc Interv Radiol, 2008 .19 :823 \u2013832 .","DOI":"10.1016\/j.jvir.2008.02.008"},{"key":"i1545-1550-16-SupplementII-82-b47","doi-asserted-by":"crossref","unstructured":"S. P. Lyden, and H. B. Smouse .TASC II and the endovascular management of infrainguinal disease., J Endovasc Ther, 2009 .16 :(Suppl II).II5 \u2013II18 .","DOI":"10.1583\/08-2659.1"},{"key":"i1545-1550-16-SupplementII-82-b49","doi-asserted-by":"crossref","unstructured":"P. C. Begovac, R. C. Thomson, and J. L. Fisher .et al.Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization., Eur J Vasc Endovasc Surg, 2003 .25 :432 \u2013437 .","DOI":"10.1053\/ejvs.2002.1909"},{"key":"i1545-1550-16-SupplementII-82-b50","doi-asserted-by":"crossref","unstructured":"J. M. Heyligers, H. J. Verhagen, and J. I. Rotmans .et al.Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts., J Vasc Surg, 2006 .43 :587 \u2013591 .","DOI":"10.1016\/j.jvs.2005.10.038"},{"key":"i1545-1550-16-SupplementII-82-b51","doi-asserted-by":"crossref","unstructured":"P. H. Lin, R. L. Bush, and Q. Yao .et al.Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model., J Surg Res, 2004 .118 :45 \u201352 .","DOI":"10.1016\/j.jss.2003.12.026"},{"key":"i1545-1550-16-SupplementII-82-b52","doi-asserted-by":"crossref","unstructured":"P. H. Lin, C. Chen, and R. L. Bush .et al.Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model., J Vasc Surg, 2004 .39 :1322 \u20131328 .","DOI":"10.1016\/j.jvs.2004.01.046"},{"key":"i1545-1550-16-SupplementII-82-b53","unstructured":"K. P. Walluscheck, S. Bierkandt, and M. Brandt .et al.Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results., J Cardiovasc Surg (Torino), 2005 .46 :425 \u2013430 ."},{"key":"i1545-1550-16-SupplementII-82-b54","unstructured":"G. Battaglia, R. Tringale, and V. Monaca .Retrospective comparison of a heparin bonded ePTFE graft and saphenous vein for infragenicular bypass: implications for standard treatment protocol., J Cardiovasc Surg (Torino), 2006 .47 :41 \u201347 ."},{"key":"i1545-1550-16-SupplementII-82-b55","unstructured":"P. Peeters, J. Verbist, and K. Deloose .et al.Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses., J Cardiovasc Surg (Torino), 2006 .47 :407 \u2013413 ."},{"key":"i1545-1550-16-SupplementII-82-b56","doi-asserted-by":"crossref","unstructured":"M. Bosiers, K. Deloose, and J. Verbist .et al.Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results., J Vasc Surg, 2006 .43 :313 \u2013319 .","DOI":"10.1016\/j.jvs.2005.10.037"},{"key":"i1545-1550-16-SupplementII-82-b57","doi-asserted-by":"crossref","unstructured":"J. M. Heyligers, T. Lisman, and H. J. Verhagen .et al.A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans., J Vasc Surg, 2008 .47 :324 \u2013329 .","DOI":"10.1016\/j.jvs.2007.10.005"},{"key":"i1545-1550-16-SupplementII-82-b58","doi-asserted-by":"crossref","unstructured":"J. R. Cohen, J. A. Mannick, and N. P. Couch .et al.Recognition and management of impending vein-graft failure. Importance for long-term patency., Arch Surg, 1986 .121 :758 \u2013759 .","DOI":"10.1001\/archsurg.1986.01400070024004"},{"key":"i1545-1550-16-SupplementII-82-b59","doi-asserted-by":"crossref","unstructured":"N. J. Lalak, K. C. Hanel, and J. Hunt .et al.Duplex scan surveillance of infrainguinal prosthetic bypass grafts., J Vasc Surg, 1994 .20 :637 \u2013641 .","DOI":"10.1016\/0741-5214(94)90289-5"},{"key":"i1545-1550-16-SupplementII-82-b60","doi-asserted-by":"crossref","unstructured":"P. Dunlop, R. D. Sayers, and A. R. Naylor .et al.The effect of a surveillance programme on the patency of synthetic infrainguinal bypass grafts., Eur J Vasc Endovasc Surg, 1996 .11 :441 \u2013445 .","DOI":"10.1016\/S1078-5884(96)80179-1"},{"key":"i1545-1550-16-SupplementII-82-b61","doi-asserted-by":"crossref","unstructured":"A. Carter, M. O. Murphy, and A. T. Halka .et al.The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program., Ann Vasc Surg, 2007 .21 :695 \u2013703 .","DOI":"10.1016\/j.avsg.2007.07.019"},{"key":"i1545-1550-16-SupplementII-82-b62","unstructured":"K. Rocha-Singh, Lesion and device-specific outcomes of SFA angioplasty: balloons, stents, atherectomy, laser, cryoplasty, etc., Presented at: Transcatheter Cardiovascular Therapeutics Las Vegas, NV, USA; October 17, 2005. Accessed October 20, 2006, at http:\/\/tct2005.com\/peripheral\/mon\/rochasingh.swf."},{"key":"i1545-1550-16-SupplementII-82-b63","doi-asserted-by":"crossref","unstructured":"M. Lenti, E. Cieri, and P. De Rango .et al.Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent., J Vasc Surg, 2007 .45 :32 \u201339 .","DOI":"10.1016\/j.jvs.2006.08.032"},{"key":"i1545-1550-16-SupplementII-82-b64","doi-asserted-by":"crossref","unstructured":"J. S. Knight, L. Smeets, and G. E. Morris .et al.Multi centre study to assess the feasibility of a new covered stent and delivery system in combination with remote superficial femoral artery endarterectomy (RSFAE)., Eur J Vasc Endovasc Surg, 2005 .29 :287 \u2013294 .","DOI":"10.1016\/j.ejvs.2004.12.016"},{"key":"i1545-1550-16-SupplementII-82-b65","unstructured":"D. Rosenthal, J. D. Martin, and P. J. Schubart .et al.Remote superficial femoral artery endarterectomy., J Cardiovasc Surg (Torino), 2004 .45 :185 \u2013192 ."},{"key":"i1545-1550-16-SupplementII-82-b66","doi-asserted-by":"crossref","unstructured":"P. W. Serruys, M. J. Kutryk, and A. T. Ong .Coronary-artery stents., N Engl J Med, 2006 .354 :483 \u2013495 .","DOI":"10.1056\/NEJMra051091"},{"key":"i1545-1550-16-SupplementII-82-b67","unstructured":"D. Scheinert, M. Ulrich, and S. Scheinert .et al.Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions., EuroIntervention, 2006 ."},{"key":"i1545-1550-16-SupplementII-82-b68","doi-asserted-by":"publisher","DOI":"10.1583\/1545-1550(2007)14[241:SVBSAS]2.0.CO;2"},{"key":"i1545-1550-16-SupplementII-82-b69","doi-asserted-by":"crossref","unstructured":"A. B. Lumsden, M. G. Davies, and E. K. Peden .Medical and endovascular management of critical limb ischemia., J Endovasc Ther, 2009 .16 :(Suppl II).II31 \u2013II62 .","DOI":"10.1583\/08-2657.1"},{"key":"i1545-1550-16-SupplementII-82-b70","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial., J Endovasc Ther, 2006 .13 :701 \u2013710 .","DOI":"10.1583\/05-1704.1"},{"key":"i1545-1550-16-SupplementII-82-b71","doi-asserted-by":"crossref","unstructured":"M. Bosiers, C. Cagiannos, and K. Deloose .et al.Drug-eluting stents in the management of peripheral arterial disease., Vasc Health Risk Manag, 2008 .4 :553 \u2013559 .","DOI":"10.2147\/VHRM.S1712"},{"key":"i1545-1550-16-SupplementII-82-b73","unstructured":"M. Dake, The Zilver PTX global registry and RCT (interview)., Endovascular Today, 2008; October .63 \u201364 ."},{"key":"i1545-1550-16-SupplementII-82-b74","unstructured":"D. Brunk, Drug-eluting stent proves durable at 6- and 12-month follow-up., American College of Surgeons: Surgery News, 2008 .4(September) :12 ."},{"key":"i1545-1550-16-SupplementII-82-b75","unstructured":"H. Smouse, A. Nikanorov, and D. LaFlash .Biomechanical forces in the femoropopliteal arterial segment., Endovascular Today, 2005 .June :60 \u201366 ."},{"key":"i1545-1550-16-SupplementII-82-b76","doi-asserted-by":"crossref","unstructured":"B. Scheller, U. Speck, and C. Abramjuk .et al.Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis., Circulation, 2004 .110 :810 \u2013814 .","DOI":"10.1161\/01.CIR.0000138929.71660.E0"},{"key":"i1545-1550-16-SupplementII-82-b77","doi-asserted-by":"crossref","unstructured":"B. Scheller, C. Hehrlein, and W. Bocksch .et al.Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter., N Engl J Med, 2006 .355 :2113 \u20132124 .","DOI":"10.1056\/NEJMoa061254"},{"key":"i1545-1550-16-SupplementII-82-b78","unstructured":"B. Scheller, and U. Speck .Solutions and future perspectives \u2014 potential solutions to the current problem: coated balloon., EuroIntervention, 2008 .4 :(suppl C).C63 \u2013C66 ."},{"key":"i1545-1550-16-SupplementII-82-b79","doi-asserted-by":"crossref","unstructured":"B. Scheller, U. Speck, and M. Bohm .Prevention of restenosis: is angioplasty the answer? Heart, 2007 .93 :539 \u2013541 .","DOI":"10.1136\/hrt.2007.118059"},{"key":"i1545-1550-16-SupplementII-82-b80","doi-asserted-by":"crossref","unstructured":"B. Scheller, C. Hehrlein, and W. Bocksch .et al.Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter., Clin Res Cardiol, 2008 .97 :773 \u2013781 .","DOI":"10.1007\/s00392-008-0682-5"},{"key":"i1545-1550-16-SupplementII-82-b81","doi-asserted-by":"crossref","unstructured":"G. Tepe, T. Zeller, and T. Albrecht .et al.Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg., N Engl J Med, 2008 .358 :689 \u2013699 .","DOI":"10.1056\/NEJMoa0706356"},{"key":"i1545-1550-16-SupplementII-82-b82","doi-asserted-by":"crossref","unstructured":"M. Werk, S. Langner, and B. Reinkensmeier .et al.Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial., Circulation, 2008 .118 :1358 \u20131365 .","DOI":"10.1161\/CIRCULATIONAHA.107.735985"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:08Z","timestamp":1777498148000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2654.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":80,"journal-issue":{"issue":"SupplementII","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1583\/08-2654.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2654.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}